Search Ontology:
ChEBI
alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)-beta-D-GalNAc-(1->4)-[alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-yl group
- Term ID
- CHEBI:62100
- Synonyms
-
- 6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->3)-[6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl
- alpha-L-fucosyl-(1->2)-alpha-L-fucosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-[alpha-L-fucosyl-(1->2)-alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminyl group
- alpha-L-Fucp-(1->2)-alpha-L-Fucp-(1->3)-beta-D-GalpNAc-(1->4)-[alpha-L-Fucp-(1->2)-alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-yl group
- DF-LDN-DF group
- Fucalpha1-2Fucalpha1-3GalNAcbeta1-4(Fucalpha1-2Fucalpha1-3)GlcNAcbeta1-
- Definition
- A glucosaminyl group derived from alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)-beta-D-GalNAc-(1->4)-[alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)]-beta-D-GlcNAc.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)-beta-D-GalNAc-(1->4)-[alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-yl group
Phenotype where environments contain alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)-beta-D-GalNAc-(1->4)-[alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-yl group
Phenotype modified by environments containing alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)-beta-D-GalNAc-(1->4)-[alpha-L-Fuc-(1->2)-alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-yl group
Human Disease Model